应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EDIT Editas Medicine, Inc.
耶稣受难日休市 03-28 16:00:00 EDT
7.42
-0.02
-0.27%
盘后
7.48
+0.06
+0.81%
18:58 EDT
最高
7.52
最低
7.37
成交量
156.12万
今开
7.46
昨收
7.44
日振幅
2.08%
总市值
6.07亿
流通市值
5.62亿
总股本
8,181万
成交额
1,159万
换手率
2.06%
流通股本
7,568万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Editas Medicine, Inc.盘中异动 股价大涨5.43%报8.35美元
自选股智能写手 · 03-21
Editas Medicine, Inc.盘中异动 股价大涨5.43%报8.35美元
Editas Medicine, Inc.盘中异动 下午盘股价大跌5.01%报8.16美元
自选股智能写手 · 03-15
Editas Medicine, Inc.盘中异动 下午盘股价大跌5.01%报8.16美元
Editas Medicine, Inc.盘中异动 早盘股价大涨5.08%报9.30美元
自选股智能写手 · 03-08
Editas Medicine, Inc.盘中异动 早盘股价大涨5.08%报9.30美元
Editas Medicine, Inc.盘中异动 急速下跌5.32%报9.97美元
自选股智能写手 · 03-05
Editas Medicine, Inc.盘中异动 急速下跌5.32%报9.97美元
Editas Medicine, Inc.盘中异动 大幅跳水5.06%报10.51美元
自选股智能写手 · 03-01
Editas Medicine, Inc.盘中异动 大幅跳水5.06%报10.51美元
美国研究综述-Okta、Salesforce、Sarepta Therapeutics
Reuters · 02-29
美国研究综述-Okta、Salesforce、Sarepta Therapeutics
BUZZ-艾迪塔斯医药公司第四季度亏损收窄,业绩上升
Reuters · 02-29
BUZZ-艾迪塔斯医药公司第四季度亏损收窄,业绩上升
Editas Medicine Inc盘中异动 股价大涨5.02%
自选股智能写手 · 02-27
Editas Medicine Inc盘中异动 股价大涨5.02%
Editas Medicine Inc 预计每股亏损 54 美分 - 财报前瞻
Reuters · 02-26
Editas Medicine Inc 预计每股亏损 54 美分 - 财报前瞻
Editas Medicine Inc 预计每股亏损 54 美分 - 财报前瞻
Reuters · 02-16
Editas Medicine Inc 预计每股亏损 54 美分 - 财报前瞻
Editas Medicine Inc盘中异动 早盘大幅上涨5.00%报7.77美元
自选股智能写手 · 02-14
Editas Medicine Inc盘中异动 早盘大幅上涨5.00%报7.77美元
Editas Medicine Inc盘中异动 早盘股价大跌5.17%
自选股智能写手 · 02-13
Editas Medicine Inc盘中异动 早盘股价大跌5.17%
Editas Medicine Inc盘中异动 早盘急速拉升5.10%报7.83美元
自选股智能写手 · 02-13
Editas Medicine Inc盘中异动 早盘急速拉升5.10%报7.83美元
Editas Medicine Inc盘中异动 股价大跌5.11%报7.24美元
自选股智能写手 · 01-31
Editas Medicine Inc盘中异动 股价大跌5.11%报7.24美元
Editas Medicine Inc盘中异动 快速跳水5.08%
自选股智能写手 · 01-27
Editas Medicine Inc盘中异动 快速跳水5.08%
Editas Medicine Inc盘中异动 下午盘大幅跳水5.04%
自选股智能写手 · 01-18
Editas Medicine Inc盘中异动 下午盘大幅跳水5.04%
Editas Medicine Inc盘中异动 急速跳水5.01%
自选股智能写手 · 01-04
Editas Medicine Inc盘中异动 急速跳水5.01%
加载更多
公司概况
公司名称:
Editas Medicine, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Editas Medicine, Inc.于2013年9月以Gengine, Inc.名字成立,后来在2013年11月更名为Editas Medicine, Inc.该公司是一家领先的基因研究公司,致力于通过纠正患者的致病基因治疗与基因相关的疾病。
发行价格:
--
{"stockData":{"symbol":"EDIT","market":"US","secType":"STK","nameCN":"Editas Medicine, Inc.","latestPrice":7.42,"timestamp":1711656000000,"preClose":7.44,"halted":0,"volume":1561182,"hourTrading":{"tag":"盘后","latestPrice":7.48,"preClose":7.42,"latestTime":"18:58 EDT","volume":70804,"amount":525352.3468,"timestamp":1711666730486},"delay":0,"floatShares":75682500,"shares":81813800,"eps":-2.016951,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":-0.02,"latestTime":"03-28 16:00:00 EDT","open":7.46,"high":7.52,"low":7.365,"amount":11591181.0713034,"amplitude":0.020833,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.016951,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"adjPreClose":7.44,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.47,"preClose":7.44,"latestTime":"09:25 EDT","volume":1811,"amount":13441.5777594,"timestamp":1711632342127},"postHourTrading":{"tag":"盘后","latestPrice":7.48,"preClose":7.42,"latestTime":"18:58 EDT","volume":70804,"amount":525352.3468,"timestamp":1711666730486},"volumeRatio":1.032915},"requestUrl":"/m/hq/s/EDIT","defaultTab":"news","newsList":[{"id":"2421045090","title":"Editas Medicine, Inc.盘中异动 股价大涨5.43%报8.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421045090","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421045090?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:43","pubTimestamp":1711028601,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时43分,Editas Medicine, Inc.股票出现波动,股价大幅拉升5.43%。截至发稿,该股报8.35美元/股,成交量13.0213万股,换手率0.16%,振幅4.29%。Editas Medicine, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Editas Medicine, Inc.公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214321861e01a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214321861e01a3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419939824","title":"Editas Medicine, Inc.盘中异动 下午盘股价大跌5.01%报8.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419939824","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419939824?lang=zh_cn&edition=full","pubTime":"2024-03-15 02:38","pubTimestamp":1710441509,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日02时38分,Editas Medicine, Inc.股票出现异动,股价快速下跌5.01%。截至发稿,该股报8.16美元/股,成交量74.0366万股,换手率0.90%,振幅4.89%。Editas Medicine, Inc.股票所在的生物技术行业中,整体跌幅为0.84%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.涨幅较大,知临集团、Psyence Biomedical Ltd.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为805.68%、213.94%、182.17%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、知临集团,振幅分别为110.40%、87.49%、76.91%。Editas Medicine, Inc.公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031502382987e79002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031502382987e79002&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417063371","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.08%报9.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417063371","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417063371?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:46","pubTimestamp":1709909189,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时46分,Editas Medicine, Inc.股票出现波动,股价急速拉升5.08%。截至发稿,该股报9.30美元/股,成交量12.2983万股,换手率0.15%,振幅3.84%。Editas Medicine, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Psyence Biomedical Ltd.、Scisparc Ltd.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为364.19%、210.00%、186.18%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、知临集团,振幅分别为146.50%、113.39%、43.48%。Editas Medicine, Inc.公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082246297918a6af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082246297918a6af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417178301","title":"Editas Medicine, Inc.盘中异动 急速下跌5.32%报9.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417178301","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417178301?lang=zh_cn&edition=full","pubTime":"2024-03-05 02:27","pubTimestamp":1709576868,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日02时27分,Editas Medicine, Inc.股票出现波动,股价大幅跳水5.32%。截至发稿,该股报9.97美元/股,成交量88.9149万股,换手率1.09%,振幅6.87%。Editas Medicine, Inc.股票所在的生物技术行业中,整体跌幅为0.35%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为2459.70%、551.32%、175.52%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Quoin Pharmaceuticals Ltd、Ocean Biomedical, Inc.,振幅分别为149.44%、103.97%、88.50%。Editas Medicine, Inc.公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030502274887e75b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030502274887e75b9c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416876579","title":"Editas Medicine, Inc.盘中异动 大幅跳水5.06%报10.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416876579","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416876579?lang=zh_cn&edition=full","pubTime":"2024-03-01 01:26","pubTimestamp":1709227566,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日01时26分,Editas Medicine, Inc.股票出现波动,股价大幅跳水5.06%。截至发稿,该股报10.51美元/股,成交量150.558万股,换手率1.84%,振幅7.77%。Editas Medicine, Inc.股票所在的生物技术行业中,整体跌幅为1.53%。其相关个股中,Enveric Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Revance Therapeutics, Inc.涨幅较大,Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Revelation Biosciences, Inc.较为活跃,换手率分别为5718.12%、1557.37%、96.29%,振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ys Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为164.60%、160.05%、95.99%。Editas Medicine, Inc.公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010126067a48371d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010126067a48371d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415056730","title":"美国研究综述-Okta、Salesforce、Sarepta Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2415056730","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415056730?lang=zh_cn&edition=full","pubTime":"2024-02-29 15:07","pubTimestamp":1709190420,"startTime":"0","endTime":"0","summary":" 路透社2月29日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 Okta、Salesforce 和 Sarepta Therapeutics。要点 * Clearwater Analytics Holdings Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性 * Okta Inc :Piper Sandler将目标价从85美元上调至110美元 * Salesforce Inc :巴克莱将目标价从325美元上调至355美元 * Sarepta Therapeutics Inc :Leerink Partners将目标价从145美元上调至165美元 * Universal Health Services Inc :Leerink Partners将目标价从174美元上调至192美元 以下是路透社周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415306361","title":"BUZZ-艾迪塔斯医药公司第四季度亏损收窄,业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2415306361","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415306361?lang=zh_cn&edition=full","pubTime":"2024-02-29 02:21","pubTimestamp":1709144499,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 2月28日 - ** 药物开发商艾迪塔斯医药 股价最高上涨30.7%,至11.58美元的逾两个月高点** 如果涨势保持,股价将创下三年多来最大单日涨幅** (link) 第四季度亏损收窄,每股亏损 0.23 美元,去年同期为每股亏损 0.88 美元。** EDIT 公布合作及其他研发收入为 6000 万美元,去年同期为 650 万美元。** 截至12月31日,公司的现金、现金等价物和有价证券为4.271亿美元** 股价在过去 12 个月中上涨了 22.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414801110","title":"Editas Medicine Inc盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414801110","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414801110?lang=zh_cn&edition=full","pubTime":"2024-02-27 23:34","pubTimestamp":1709048067,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日23时34分,Editas Medicine Inc股票出现波动,股价大幅拉升5.02%。截至发稿,该股报8.47美元/股,成交量44.7161万股,换手率0.55%,振幅4.34%。Editas Medicine Inc股票所在的生物技术行业中,整体跌幅为0.42%。其相关个股中,Janux Therapeutics Inc、Viking Therapeutics Inc、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃,换手率分别为345.61%、159.64%、34.38%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Janux Therapeutics Inc、Viking Therapeutics Inc,振幅分别为87.23%、70.86%、50.96%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227233427861d8e2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227233427861d8e2d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414880932","title":"Editas Medicine Inc 预计每股亏损 54 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414880932","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414880932?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:17","pubTimestamp":1708957043,"startTime":"0","endTime":"0","summary":" * 爱迪达斯医药公司 将于2月28日公布截至2023年12月31日的财报,预计季度收入将有所增长。* 根据LSEG的数据,12位分析师的平均预期显示,这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的654万美元增长21.5%,达到794.3万美元。* LSEG分析师对Editas Medicine Inc的平均预期为每股亏损54美分。* 华尔街对 Editas Medicine Inc 的 12 个月目标价中位数为 15.00 美元,高于其最新收盘价 7.81 美元。2月26日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411266360","title":"Editas Medicine Inc 预计每股亏损 54 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2411266360","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411266360?lang=zh_cn&edition=full","pubTime":"2024-02-16 22:14","pubTimestamp":1708092849,"startTime":"0","endTime":"0","summary":" * 爱迪达斯医药公司 预计将在2月20日公布截至2023年12月31日的业绩报告。* 根据LSEG的数据,12位分析师的平均预期显示,这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的654万美元增长21.5%,达到794.3万美元。* LSEG分析师对Editas Medicine Inc的平均预期为每股亏损54美分。* 华尔街对 Editas Medicine Inc 的 12 个月目标价中位数为 15.00 美元,高于其最新收盘价 8.31 美元。2月16日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411758877","title":"Editas Medicine Inc盘中异动 早盘大幅上涨5.00%报7.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411758877","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411758877?lang=zh_cn&edition=full","pubTime":"2024-02-14 23:20","pubTimestamp":1707924008,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日23时20分,Editas Medicine Inc股票出现波动,股价急速拉升5.00%。截至发稿,该股报7.77美元/股,成交量38.8586万股,换手率0.48%,振幅2.98%。Editas Medicine Inc股票所在的生物技术行业中,整体涨幅为0.82%。其相关个股中,Engene Holdings Inc C/Wts 31/10/2028 Cl A、Cogent Biosciences Inc、Engene Holdings Inc涨幅较大,Kintara Therapeutics Inc、Transcode Therapeutics Inc、Azitra Inc较为活跃,换手率分别为44.74%、28.22%、27.84%,振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028 Cl A、Engene Holdings Inc、Briacell Therapeutics Corp C/Wts,振幅分别为208.62%、51.18%、33.33%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214232008861d53c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214232008861d53c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411452368","title":"Editas Medicine Inc盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411452368","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411452368?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:30","pubTimestamp":1707834642,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时30分,Editas Medicine Inc股票出现异动,股价快速下挫5.17%。截至发稿,该股报7.71美元/股,成交量6.6875万股,换手率0.08%,振幅0.31%。Editas Medicine Inc股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大,Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃,换手率分别为291.59%、79.28%、28.69%,振幅较大的相关个股有Lisata Therapeutics Inc、Coherus Biosciences Inc、Avid Bioservices Inc,振幅分别为6.62%、4.26%、3.25%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213223042861d5052&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213223042861d5052&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411821913","title":"Editas Medicine Inc盘中异动 早盘急速拉升5.10%报7.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411821913","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411821913?lang=zh_cn&edition=full","pubTime":"2024-02-13 00:18","pubTimestamp":1707754737,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日00时18分,Editas Medicine Inc股票出现波动,股价快速拉升5.10%。截至发稿,该股报7.83美元/股,成交量49.5402万股,换手率0.61%,振幅5.65%。Editas Medicine Inc股票所在的生物技术行业中,整体跌幅为0.67%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213001857791112db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213001857791112db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407243398","title":"Editas Medicine Inc盘中异动 股价大跌5.11%报7.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407243398","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407243398?lang=zh_cn&edition=full","pubTime":"2024-01-31 01:42","pubTimestamp":1706636568,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日01时42分,Editas Medicine Inc股票出现波动,股价快速下挫5.11%。截至发稿,该股报7.24美元/股,成交量55.4664万股,换手率0.68%,振幅3.54%。Editas Medicine Inc股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,Neximmune Inc、Pepgen Inc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Neximmune Inc、Panbela Therapeutics Inc、Gri Bio Inc较为活跃,换手率分别为1310.37%、265.68%、183.23%,振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Gri Bio Inc,振幅分别为800.00%、218.65%、89.01%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401310142487a3fbe1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401310142487a3fbe1d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406711097","title":"Editas Medicine Inc盘中异动 快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406711097","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406711097?lang=zh_cn&edition=full","pubTime":"2024-01-27 02:20","pubTimestamp":1706293206,"startTime":"0","endTime":"0","summary":"北京时间2024年01月27日02时20分,Editas Medicine Inc股票出现异动,股价大幅下跌5.08%。Editas Medicine Inc股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Corbus Pharmaceuticals Holdings In、Zura Bio Limited C/Wts 20/03/2028 、Ys Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Panbela Therapeutics Inc、Tc Biopharm Plc、Processa Pharmaceuticals Inc较为活跃,换手率分别为2478.64%、1070.37%、746.20%,振幅较大的相关个股有Corbus Pharmaceuticals Holdings In、Panbela Therapeutics Inc、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为280.92%、47.38%、46.05%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240127022006790c840e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240127022006790c840e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404839891","title":"Editas Medicine Inc盘中异动 下午盘大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404839891","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404839891?lang=zh_cn&edition=full","pubTime":"2024-01-18 03:06","pubTimestamp":1705518405,"startTime":"0","endTime":"0","summary":"北京时间2024年01月18日03时06分,Editas Medicine Inc股票出现异动,股价急速下跌5.04%。Editas Medicine Inc股票所在的生物技术行业中,整体跌幅为0.97%。其相关个股中,Revolution Medicines Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Kintara Therapeutics Inc、Zyversa Therapeutics Inc、Windtree Therapeutics Inc较为活跃,换手率分别为1310.69%、920.58%、81.56%,振幅较大的相关个股有Dermata Therapeutics Inc C/Wts 13/08/2026 、Moolec Science Sa C/Wts 、Revolution Medicines Inc C/Wts ,振幅分别为170.37%、96.36%、76.26%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401180306457909c29c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401180306457909c29c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400803665","title":"Editas Medicine Inc盘中异动 急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400803665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400803665?lang=zh_cn&edition=full","pubTime":"2024-01-04 04:19","pubTimestamp":1704313165,"startTime":"0","endTime":"0","summary":"北京时间2024年01月04日04时19分,Editas Medicine Inc股票出现异动,股价大幅跳水5.01%。截至发稿,该股报9.48美元/股,成交量80.6779万股,换手率0.99%,振幅4.61%。Editas Medicine Inc股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Neximmune Inc、Geovax Labs Inc C/Wts 29/09/2025、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大,Neximmune Inc、Abvc Biopharma Inc、First Wave Biopharma Inc较为活跃,换手率分别为5632.98%、1092.13%、994.92%,振幅较大的相关个股有Neximmune Inc、Nutriband Inc C/Wts 30/09/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 ,振幅分别为214.74%、106.00%、72.14%。Editas Medicine Inc公司简介:Editas Medicine Inc 是一家基因组编辑公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040419267a382c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040419267a382c28&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.editasmedicine.com","stockEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1625},{"period":"3month","weight":-0.2675},{"period":"6month","weight":-0.0487},{"period":"1year","weight":0.0013},{"period":"ytd","weight":-0.2675}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Editas Medicine, Inc.于2013年9月以Gengine, Inc.名字成立,后来在2013年11月更名为Editas Medicine, Inc.该公司是一家领先的基因研究公司,致力于通过纠正患者的致病基因治疗与基因相关的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.061207},{"month":2,"riseRate":0.375,"avgChangeRate":0.022799},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.0355},{"month":4,"riseRate":0.375,"avgChangeRate":-0.0463},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003621},{"month":6,"riseRate":0.625,"avgChangeRate":0.090173},{"month":7,"riseRate":0.625,"avgChangeRate":0.007052},{"month":8,"riseRate":0.625,"avgChangeRate":0.080833},{"month":9,"riseRate":0.125,"avgChangeRate":-0.128196},{"month":10,"riseRate":0.5,"avgChangeRate":-0.040926},{"month":11,"riseRate":0.625,"avgChangeRate":0.144442},{"month":12,"riseRate":0.375,"avgChangeRate":0.101676}],"exchange":"NASDAQ","name":"Editas Medicine, Inc.","nameEN":"Editas Medicine"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Editas Medicine, Inc.,EDIT,Editas Medicine, Inc.股票,Editas Medicine, Inc.股票老虎,Editas Medicine, Inc.股票老虎国际,Editas Medicine, Inc.行情,Editas Medicine, Inc.股票行情,Editas Medicine, Inc.股价,Editas Medicine, Inc.股市,Editas Medicine, Inc.股票价格,Editas Medicine, Inc.股票交易,Editas Medicine, Inc.股票购买,Editas Medicine, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}